|

MP0533 with Obinutuzumab pretreatment Clinical Trials

1 actively recruiting trial

Also known as: Arm A

Pipeline

Phase 1/2: 1

Top Sponsors

  • Molecular Partners AG1

Indications

  • Acute1
  • Myeloid1
  • Newly Diagnosed1
  • Leukemia1
  • Cancer1

Other1 trial

Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.